🇺🇸 FDA
Patent

US 6214388

Immunoliposomes that optimize internalization into target cells

expired A61KA61K38/00A61K47/6849

Quick answer

US patent 6214388 (Immunoliposomes that optimize internalization into target cells) held by The Regents of the University of California expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61K47/6849, A61K47/6913, A61K9/127